KA
PFE icon

Kozak & Associates’s Pfizer PFE Stock Holding History

Kozak & Associates’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.2K Sell
637
-273
-30% -$7.14K ﹤0.01% 231
2026
Q1 		$24.9K Buy
910
+212
+30% +$5.64K ﹤0.01% 187
2025
Q4 		$17.8K Sell
698
-128
-15% -$3.23K ﹤0.01% 205
2025
Q3 		$20.7K Buy
826
+421
+104% +$10.4K ﹤0.01% 191
2025
Q2 		$10.3K Buy
405
+7
+2% +$163 ﹤0.01% 239
2025
Q1 		$8.8K Buy
398
+6
+2% +$157 ﹤0.01% 238
2024
Q4 		$10.4K Sell
392
-236
-38% -$6.4K ﹤0.01% 241
2024
Q3 		$18.6K Buy
628
+9
+1% +$263 ﹤0.01% 191
2024
Q2 		$17.2K Buy
619
+9
+1% +$248 ﹤0.01% 183
2024
Q1 		$17.6K Buy
610
+9
+1% +$250 ﹤0.01% 189
2023
Q4 		$17K Sell
601
-168
-22% -$5.08K 0.01% 198
2023
Q3 		$25.5K Buy
769
+4
+0.5% +$141 0.01% 177
2023
Q2 		$28.1K Buy
765
+3
+0.4% +$117 0.01% 172
2023
Q1 		$31.1K Sell
762
-140
-16% -$6.05K 0.01% 171
2022
Q4 		$46K Buy
902
+3
+0.3% +$144 0.02% 154
2022
Q3 		$38K Buy
899
+3
+0.3% +$146 0.02% 156
2022
Q2 		$47K Sell
896
-361
-29% -$18.4K 0.03% 151
2022
Q1 		$62K Hold
1,257
– – 0.04% 142
2021
Q4 		$62K Buy
1,257
+323
+35% +$16K 0.04% 142
2021
Q3 		$46K Buy
+934
New +$41.4K 0.03% 164

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Kozak & Associates's PFE Position: Q2 2026 in Review

Kozak & Associates reduced its Pfizer (PFE) stake by 30% in Q2 2026, selling an estimated $7.14K and leaving 637 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #231.

Kozak & Associates first reported a position in PFE in Q3 2021 and has held it in 20 quarters since. The position peaked at $62K in Q1 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Kozak & Associates held 637 shares of Pfizer worth $15.2K as of Q2 2026.
  • Kozak & Associates sold 273 Pfizer shares in Q2 2026, an estimated $7.14K.
  • Pfizer made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #231 holding.
  • Kozak & Associates first reported a position in Pfizer in Q3 2021 and has held it in 20 quarters since.
  • Kozak & Associates's Pfizer position peaked at $62K in Q1 2022.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.